Literature DB >> 12660471

Clear cell sarcoma of the kidney with invasion of the inferior vena cava.

D Rosso1, G P Ghignone, D Bernardi, A Zitella, G Casetta, A De Zan, A Tizzani.   

Abstract

OBJECTIVE: We present a case of clear cell sarcoma of the kidney (CCSK) in 53-year-old white man who was treated with surgery. This case represents the oldest patient with CCSK published in the English literature.
METHODS: Right radical nephrectomy with lymphadenectomy and thrombectomy was performed.
RESULTS: Histological findings indicated a CCSK. Tumor cells showed positive vimentin staining.
CONCLUSION: CCSK is considered a rare and highly malignant renal tumor. The malignant nature may relate not only to the biological features of these tumor cells, but also to the high resistance against radiation and chemotherapy. The treatment of CCSK has been a subject of controversy. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12660471     DOI: 10.1159/000068756

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  5 in total

1.  Adult clear cell sarcoma of the kidney: a case report.

Authors:  Ali R Kural; Bulent Onal; Hamdi Ozkara; Cansel Cakarir; Inci Ayan; Fulya Y Agaoglu
Journal:  BMC Urol       Date:  2006-04-03       Impact factor: 2.264

2.  Renal sarcoma and associated malignant pulmonary embolism: a report of 2 cases.

Authors:  Jonathan S Taylor; Rodney H Breau; Ilias Cagiannos; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

3.  Clear cell sarcoma of kidney: A rare entity.

Authors:  Nirupma Lal; Atin Singhai
Journal:  Indian J Med Paediatr Oncol       Date:  2011-07

4.  Clear cell sarcoma of the kidney in an adult: a case report and literature review.

Authors:  Mingxin Cao; Junlong Zhang; Huisi Ma; Yueyou Liang
Journal:  Transl Cancer Res       Date:  2022-01       Impact factor: 1.241

5.  Clear cell sarcoma of the kidney in a 62-year-old patient presenting with generalized pruritus.

Authors:  Yuxi Zhang; Jun Li; Yan Wang
Journal:  BMC Cancer       Date:  2019-11-01       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.